Scientific Programme 2017

Please click here to access a PDF version of the following:

Final Programme – Timetable Overview

Final Programme – Oral Programme

Final Programme – Poster Listing

Thursday 6 April 2017

0830-1000Pre-Congress Workshop – Hot HIV topics in Latin America
Chairs: Ernesto Martinez, Colombia, Alejandro Afani and
Carlos Beltran, Chile

0830-0850HIV in Latin America “a young epidemic”
Pedro Zitko, Santiago, Chile
0850-0910Ladies first “always a problem”
Isabel Cassetti, Buenos Aires, Argentina
0910-0930Too late to care “the same old story”
Ana P Celi de la Torre, Quito, Ecuador
0930-1000Roundtable: Facing-up to the epidemic in Latin America: from evidence to action
Speakers, chairs and audience

1000-1015Official Opening
Co chairs: Juan Sierra Madero, Mexico and Mauro Schechter, Brazil

1015-1045The promise of curing HCV as a way of improving HIV treatment: A novel strategy
Carl Dieffenbach, USA

1045-1115Is it possible to cure HIV infection? A clinician’s perspective
Steven Deeks, USA

1115-1130Coffee

1130-1300Are guidelines guiding Latin American care providers?
Co chairs: Isabel Cassetti, Argentina and Anton Pozniak, UK
Overview of International Guidelines
Anton Pozniak, UK
HIV/AIDS treatment guidelines: Mexico
Luis Mosqueda, Mexico
HIV/AIDS guidelines on cART: the Brazilian perspective
Adele Schwartz Benzaken, Brazil
ARV guidelines in Argentina
Discussion

1300-1400Scientific Posters and Lunch

1400-1500Two Challenges: HCV and Ageing
Co chairs: Marcelo Losso, Argentina and Mark Nelson, UK
Treatment of Hepatitis C ‘Where are we now?’
Mario Pessoa, Brazil

Retreatment of patients failing AAD therapy in Spain in a real life setting:
updated results from the HEPCREsp GEHEP004 cohort
Federico Garcia, Spain

Increased age-adjusted mortality and incidence of non-AIDS defining events
among people living with HIV enrolled after 50 years and aging in care in Latin America.
A CCASAnet cohort study
Pablo Belaunzaran-Zamudio, Mexico

1500-1630The 90s in the Americas
Co chairs: Juan Sierra Madero, Mexico and Adele Schwartz Benzaken, Brazil
Testing
Marcelo Losso, Argentina
Treatment
Pedro Cahn, Argentina
Retention in care/adherence
Carlos Beltran, Chile
Prioritization of treatment: Is it necessary?
Mauro Schechter, Brazil

1630-1700Coffee

1700-1830Industry Symposium: Dolutegravir at the Core of Therapy (ViiV)

1830-1930Welcome Reception around the posters

Friday 7 April 2017

0900-1030Industry Symposium: Optimizing HIV Treatment in Latin America (Gilead)

1030-1045Coffee

1045-1145Adolescents Born with HIV: Life Must Go On
Co chairs: Monica Thormann, Dominican Republic and Jean W Pape, Haiti
In collaboration with the International AIDS Society (IAS)
The second decade: cashing in on evolving capacities for better outcomes
Linda-Gail Bekker, South Africa

Adolescents perspective
Daisy Machado, Brazil
MTCT: a paediatric perspective
Jorge Pinto, Brazil
Panel Discussion

1145-1245Barriers to treatment success in Hep C
Co chairs: Carl Dieffenbach, USA and Mario Pessoa
Access to drugs/treating patients
Pedro Cahn, Argentina
Re-infection
Mark Nelson, UK
When will I not treat anymore?
Esteban Gonzalez Ballerga, Argentina
Discussion

1245-1345Scientific Posters and Lunch

1345-1500Challenging cases in Hepatitis – Interactive Case Study Session
Co chairs: Ricardo Diaz, Brazil and Anton Pozniak
Case 1: hepatitis C co-infected case
Mario Pessoa, Brazil
Case 2: hepatitis B co-infected case
Mark Nelson, UK
Case 3: triple co-infected case
Jorge Santana, Puerto Rico

1500-1515Coffee

1515-1645PrEP in the Region
Co chairs: Esper Kallas, Brazil and Roy Gulick, USA
An overview: where we are, what are the issues, what’s coming?
Esper Kallas, Brazil
Rolling out PrEP
Beatriz Grinsztejn, Brazil
Unseen benefits of PrEP programmes
Florentino Badial Hernandez, Mexico

The importance of PrEP from a community perspective
Owen Ryan, Switzerland

1645-1700Coffee

1700-1830Industry Symposium: KNOW YOUR PATIENTS – ACT NOW! (Merck)
Chair: Mauro Schechter, Brazil

Saturday 8 April 2017

0900-1000Industry Symposium: HCV Treatment: From Clinical Trials to
Real World Experience (Gilead)
Chair: Maria Cassia Mendes Correa, Brazil

1000-1015Coffee

1015-1145Public health perspectives in Viral Hepatitis:
Building-up a Public Health Response to Viral Hepatitis B and C Epidemics in the
Region of the Americas

In collaboration with the Pan American Health Organization (PAHO)
Viral hepatitis B and C in the Americas
Massimo Ghidinelli, USA
What would it take to eliminate hepatitis B & C in the region of the Americas?
Homie Razavi, USA
Access to compassionate treatment for HCV in Argentina: review of 1 year’s
experience
Gabriella Vidiella, Argentina
Expanding access to HCV treatment: treatment priorities and overcoming barriers
Adele Schwartz Benzaken, Brazil
Elimination of HBV perinatal transmission: how far from achievement?
Chloe Thio, USA

1145-1315Implementation Science and New Relevant Data
Co chair: Daniel Kuritzkes, USA and Ian Weller, UK
Review of key data since the 2016 Americas Congress
Ricardo Sobhie Diaz
Update from CROI
Luis Soto-Ramirez, Mexico
Efficacy and safety of switching to EVG/COBI/FTC/TAF in virologically
suppressed women
Monica Thormann, Dominican Republic
Significant efficacy and long-term safety difference with TAF-based
STR in treatment-naive adults
Carlos Falistocco, Argentina
Implementation challenges: a regional perspective
Juan Sierra-Madero

1315-1415Scientific Posters and Lunch

1415-1530‘Challenging cases in HIV’
Interactive case session in collaboration with the International Antiviral Society-USA
(IAS-USA)
Issues in Opportunistic Infection Prevention: Focus on Tuberculosis
Patrice Severe, Haiti
Prepping for Pre exposure Prophylaxis (PrEP)
Alicia Pineirua Menendez, Mexico
Antiretroviral Therapy: What to start

Omar Sued, Argentina

1530-1600Treatment as prevention in HCV and drug users covering Hepatitis B and C
Esteban Ballerga, Argentina

1600-1630New ART strategies and the future of ART
Daniel Kuritzkes, USA

1630-1645Official Close